Do you know fewer than 5% of Latinos participate in federal clinical trials? There is a historical lack of targeted research about Latino health inequities and how to address them, and a lack of diversity in clinical trials. Researchers thus have less chance to develop new treatments for this population, which suffers a heavy burden of certain cancers, dementia, obesity, and mental health issues. That's why we're excited to use #SaludTues on April 6, 2021, to tweet about how to increase Latino participation in clinical trials to prevent health disparities, to mark National Minority Health Month in April. WHAT: Tweetchat: “Latino Participation Is Vital in Clinical Trials"
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, April 6, 2021
WHERE: On Twitter with hashtag ...
Historically and presently, Latinos are underrepresented in clinical research. Researchers want to increase diverse participation in clinical trials to ensure that Latinos and other underrepresented populations benefit from advances in public health and medicine, including personalized medicine. This is especially important amid a harmful pandemic that is disproportionately impacting Latinos. In hopes of increasing awareness among Latinos and people burdened by COVID-19, the National Health Institute's (NIH) Community Engagement Alliance (CEAL) Against COVID-19 Disparities Program created a new series of bilingual videos on clinical trials about vaccines and clinical trials to prevent and treat COVID-19. "[Our] program focuses on addressing misinformation around COVID-19, ...
Across the board, Latinos are underrepresented in clinical research. Without adequate Latino and minority representation in clinical trials, researchers cannot find differential effects among groups nor advance public health and medicine. To address this, researchers across the country, like those at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, are creating educational interventions to recruit certain racial/ethnic groups in diseases like Alzheimer's that are on the rise among minorities. "Studies should represent the demographics of the country," Dr. Jonca Bull, an assistant commissioner on minority health at the Food and Drug Administration, said in a recent statement. "We need to close that gap so we can better ...
Latinos face an uphill battle when it comes to their health. They suffer many inequities, which are worsened amid the COVID-19 pandemic. Beyond that, there is a historical lack of targeted research about these inequities and how to address them, and a lack of diversity in clinical trials. This is the focus of a new webinar, "Conversations on Cancer: Latino Community—Achieving Equity in Cancer Clinical Trials," set for 1 p.m. ET Thursday, Sept. 24, 2020. The event is sponsored by the FDA's Oncology Center of Excellence. Register for the webinar. Panelists are: Amelie G. Ramirez, DrPh, Director of Salud America!, Professor and Chair of the Department of Population Health Sciences, and Director of the Institute for Health Promotion Research, all at UT Health San Antonio
...
Dr. Amelie G. Ramirez, director of Salud America! and the Institute for Health Promotion Research at UT Health San Antonio, has been named one of the "The Cancer Health 25: Change Makers" by Cancer Health magazine. The magazine recognizes individuals who "make a difference every day." "They have each experienced cancer, either personally or through someone they love," according to the magazine. "And it has changed them, made them want to give back and given them a mission to make a difference for others living with cancer." Read about Ramirez and the other 25 change makers here.
Dr. Ramirez & Her Health Promotion Research
Ramirez is an internationally recognized health researcher at UT Health San Antonio. Here, she is professor and chair of the Department of Population ...
We are in the “golden age” of cancer drug development with over 50 drugs approved for cancer treatment in the past three years. But things aren’t golden for everyone. That is part of the reason why Dr. Amelie G. Ramirez of UT Health San Antonio co-hosted the 2nd Advancing the Science of Cancer (ASCL) conference Feb. 26-28, 2020, in San Antonio. The conference united nearly 300 researchers, oncologists, physicians, community leaders, policymakers and students. While looking at Latino cancer, the audience strives for solutions that will work for all. "We have to ensure that cancer treatments—or intervention, prevention, and outreach methods—work for all people," said Ramirez, who directs the Institute for Health Promotion Research at UT Health San Antonio. The IHPR ...
Did you know that Latinos comprise less than 7.6% of clinical trial participants? This means that researchers have less chances to develop new cancer treatments for this population, which suffers a heavy burden of certain cancers, obesity, and mental health issues. Join us and use #SaludTues on Jan. 21, 2020, to tweet about how to increase Latino participation in clinical trials to prevent health disparities, in celebration of the quickly approaching Advancing the Science of Cancer in Latinos conference: WHAT: #SaludTuesTweetchat: Engaging Latinos in Clinical Trials
DATE/TIME: 1-2 p.m. EST (Noon-1 p.m. CST), Tuesday, January 21, 2020
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludAmerica
CO-HOSTS: FDA Minority Health & Health Equity ...
The rise of the Latino population makes it urgent to tackle disparities in obesity, diabetes, and cancer. But did you know fewer than 5% percent of Latinos participate in federal clinical trials? Researchers thus have less chance to develop new cancer treatments for this population, which suffers a heavy burden of certain cancers, obesity, and mental health issues. That's why we're excited to use #SaludTues on Oct. 16, 2018, to tweet about how to increase Latino participation in clinical trials to prevent health disparities, as Hispanic Heritage Month draws to a close! WHAT: Bilingual Tweetchat: “Hispanic Heritage Month: Latinos and Clinical Trials”
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, Oct. 16, 2017
WHERE: On Twitter with hashtag #SaludTues
HOST: ...
For years, studies have shown that Latinos have a profound mistrust of doctors and scientists. Consequently, Latinos participate in clinical trials at far lower rates than other ethnic groups, which perpetuates the health disparities seen with many diseases like Alzheimer’s and certain cancers. This also makes it harder for researchers to find treatments that work best for Latinos. Minorities actually represent less than 30% of those enrolled in clinical trials sponsored by the National Institutes of Health (NIH), according to a recent report. Latinos comprised less than 7.6% of trial participants. “There hasn’t been a single [prostate] screening trial including a significant number of Latinos or blacks … yet it impacts our practice and we have no data to know if it ...
